Open Access

[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin

  • Authors:
    • Yang Qu
    • Peng Xia
    • Shanyong Zhang
    • Su Pan
    • Jianwu Zhao
  • View Affiliations

  • Published online on: October 29, 2021     https://doi.org/10.3892/or.2021.8213
  • Article Number: 2
  • Copyright : © Qu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 33: [Related article:] 1177-1184, 2015; DOI: 10.3892/or.2014.3698

Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that the western blotting data featured in Figs. 2B and 4D, the flow cytometric data in Fig. 4A and the tumour images shown in Fig. 6A were strikingly similar to data appearing in different form in other articles at different research institutes. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

January-2022
Volume 47 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qu Y, Xia P, Zhang S, Pan S and Zhao J: [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin. Oncol Rep 47: 2, 2022
APA
Qu, Y., Xia, P., Zhang, S., Pan, S., & Zhao, J. (2022). [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin. Oncology Reports, 47, 2. https://doi.org/10.3892/or.2021.8213
MLA
Qu, Y., Xia, P., Zhang, S., Pan, S., Zhao, J."[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin". Oncology Reports 47.1 (2022): 2.
Chicago
Qu, Y., Xia, P., Zhang, S., Pan, S., Zhao, J."[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin". Oncology Reports 47, no. 1 (2022): 2. https://doi.org/10.3892/or.2021.8213